Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Steroids policy delayed until March 2015
horse racing
“This is a complex issue and while we are disappointed not to be in a position to launch on 1 January, I have no doubt that we are doing the right thing in not trying to rush its introduction."

Clarification sought with riders, stakeholders and owners on certain elements

The British Horseracing Authority (BHA) has announced that full implementation of its zero-tolerance policy regarding the use of anabolic steroids has been delayed until March 2015.
 
In a statement the BHA said that the delay will allow more time to work with riders, owners and stakeholders, to clarify certain elements of the new rules and to secure consensus from all affected parties.

First announced in June 2014, the policy aims to ensure that British Racing remains at the forefront of tackling an issue that ranks amongst the biggest threats faced by any world sport.

The decision to delay the introduction has been welcomed by a number of horse racing organisations.

Richard Arnold, chief executive of the National Trainers Federation (NTF), said: “The NTF fully supports the BHA’s general policy on anabolic steroids and we are keen for its implementation to run smoothly.

Unfortunately some practical issues remain unresolved so we welcome the BHA’s decision to delay the introduction until these are ironed out. We are committed to working with all the parties involved to ensure the rules and procedures achieve the agreed objectives.”

Richard Wayman, Racehorse Owners Association's (ROA) chief executive, said: “The ROA unequivocally supports a zero tolerance approach to anabolic steroids but we recognise application of the new policy is not without its challenges including, for example, establishing who is responsible for a horse when it is not stabled with its trainer or owner.

Delaying implementation for a short period of time to allow such issues to be fully worked through is eminently sensible as the priority must be to ensure the new rules operate as intended and also that they are fully communicated to those directly involved before they become effective.”

Jamie Stier, director of raceday operations and regulation for BHA, said: “This is a complex issue and while we are disappointed not to be in a position to launch on 1 January, I have no doubt that we are doing the right thing in not trying to rush its introduction."

Full details of the policy can be found at www.britishhorseracing.com


 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.